Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 3Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Other hematologic neoplasm 3Other solid neoplasm 2Other 2Head & Neck 2Gynecologic 2CNS 2Thoracic 1Sarcoma 1Plasma cell 1Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Tracheal Diseases 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Lung Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Adenoid Cystic 1

Interventions

Carboplatin 182pembrolizumab 157Pemetrexed 132Cisplatin 98Drug Therapy 68Paclitaxel 61osimertinib 55Nivolumab 50Magnetic Resonance Spectroscopy 50Specimen Handling 49durvalumab 48Radiotherapy 48Docetaxel 44atezolizumab 43Etoposide 40Bevacizumab 39tislelizumab 33Blood Specimen Collection 33Radiosurgery 31Gemcitabine 29130-nm albumin-bound paclitaxel 28Immunotherapy 26Immune Checkpoint Inhibitors 24cemiplimab 23Injections 22aflutinib 20Cetuximab 19Biopsy 18Platinum Compounds 17Surgical Procedures, Operative 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Tablets × Thoracic × Clear all
NCT03556228 2025-12-11

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

VM Oncology, LLC

Phase 1/2 Recruiting
242 enrolled
GastrointestinalHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Adenoid Cystic, Esophageal Neoplasms, Head and Neck Neoplasms, Laryngeal Diseases, Lung Neoplasms, Mesothelioma, Neoplasm Metastasis, Pancreatic Neoplasms, Salivary Gland Neoplasms, Tracheal Diseases, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡